Roundup Cancer Lawsuit News

Monsanto Battles Decision Big For Roundup Lawsuits

Monsanto is fighting a decision levied in California that allows labeling warning Roundup can cause cancer, which was a boon for Roundup cancer lawsuits.

Friday, March 24, 2017 - Monsanto is attempting to fight a decision recently made in California to require labeling on their Roundup products warning of cancer causing chemical that acts as the active ingredient in the weed killer. A California judge in January dismissed a claim made by Monsanto that the state could not use a non-U.S. body's determination regarding the carcinogenic nature of glyphosate to attached a warning label to its popular weedkiller. The state of California had previously employed a decision made by the International Agency for Research on Cancer to classify glyphosate as "probably carcinogenic to humans" to require a warning label on all Roundup products.

The decision to attach the warning label came as welcome news to plaintiffs that have filed Roundup lawsuits against Monsanto. The Monsanto Roundup lawsuits claim that the company's weedkiller has carcinogenic properties, and that bears responsibility for the cancer diagnoses suffered by patients who have used their Roundup products without being properly warned. The claims against Monsanto were consolidated into multidistrict litigation in California in December, and most of the Monsanto Roundup lawsuits against Johnson & Johnson have been filed in the state. It's a big reason why the decision to require labeling in the state of California was such a big deal for both plaintiffs and for Monsanto as the claims against the agricultural giant progress.

Monsanto was upset with the use of the IARC's determination concerning glyphosate because they consider the organization to be an "unelected, undemocratic, unaccountable, and foreign body." Monsanto Roundup cancer lawyers have argued that California shouldn't be allowed to base evidence for warning labels based on information gathered by a "nondelegation doctrine." However, the California judge presiding over the lawsuit brought by Monsanto rejected those and all the six arguments brought by the Monsanto attorneys and allowed the required warning labels to stand. The court did not consider the evidence produced by the IARC as dismissible under the California constitution as Monsanto had argued.

The active ingredient in Roundup, glyphosate, has long been a controversial compound. It was given a number of different designations are the EPA when it was first being vetted as an active ingredient for use in weed killers, going from possibly carcinogenic to not carcinogenic after a series of tests that many claim Monsanto illegally tampered with. Monsanto either owned or had a stake in the works of a number of testing companies that the EPA relied on to retrieve data on glyphosate and the carcinogenic properties of the chemical. Plaintiffs claim that Monsanto intentionally had those results doctored in order for their weedkiller to pass by the governmental body for use in the U.S.

These developments caused many to consider Monsanto as intentionally putting profits before consumers health, and the decision to require warning labels in California is just one step back in the direction of consumer safety. At least that is how the California state judge saw it when the arguments in the lawsuit brought by Monsanto against the state over the labeling was dismissed.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.